Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcGuinness, Greer-
dc.contributor.authorKim, Yeonsoo-
dc.date.accessioned2020-12-16T15:36:37Z-
dc.date.available2020-12-16T15:36:37Z-
dc.date.issued2020-06-26-
dc.identifier.citationMcGuinness, G., & Kim, Y. (2020). Sulforaphane treatment for autism spectrum disorder: A systematic review. EXCLI Journal, 19, 892-903. https://doi.org/10.17179/excli2020-2487de
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/39908-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21798-
dc.description.abstractAutism Spectrum Disorder (ASD) is defined as a neurodevelopmental condition characterized by social communication impairment, delayed development, social function deficit, and repetitive behaviors. The Center for Disease Control reports an increase in ASD diagnosis rates every year. This systematic review evaluated the use of sulforaphane (SFN) therapy as a potential treatment option for individuals with ASD. PubMed.gov, PubMed Central, Natural Medicines, BoardVitals, Google Scholar and Medline were searched for studies measuring the effects of SFN on behavior and cognitive function. All five clinical trials included in this systematic review showed a significant positive correlation between SFN use and ASD behavior and cognitive function. The current evidence shows with minimal side effects observed, SFN appears to be a safe and effective treatment option for treating ASD.den
dc.language.isoen-
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmundde
dc.relation.ispartofseriesEXCLI Journal;Vol. 19. 2020, pp. 892-903-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectSulforaphaneen
dc.subjectAutism Spectrum Disorderen
dc.subjectGlucosinolatesen
dc.subjectTreatmenten
dc.subjectCAMen
dc.subject.ddc610-
dc.titleSulforaphane treatment for autism spectrum disorderen
dc.title.alternativea systematic reviewen
dc.typeText-
dc.type.publicationtypearticle-
eldorado.identifier.urlhttps://www.excli.de/index.php/excli/article/view/2487-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.dnb.zdberstkatidtrue-
Appears in Collections:Review Articles 2020

Files in This Item:
File Description SizeFormat 
excli2020-2487.pdfDNB159.81 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons